Alison Roos

744 total citations
16 papers, 360 citations indexed

About

Alison Roos is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Alison Roos has authored 16 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Cancer Research and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Alison Roos's work include Glioma Diagnosis and Treatment (5 papers), Lung Cancer Treatments and Mutations (5 papers) and interferon and immune responses (4 papers). Alison Roos is often cited by papers focused on Glioma Diagnosis and Treatment (5 papers), Lung Cancer Treatments and Mutations (5 papers) and interferon and immune responses (4 papers). Alison Roos collaborates with scholars based in United States, Netherlands and Canada. Alison Roos's co-authors include Nhan L. Tran, Joseph C. Loftus, Zonghui Ding, Harshil Dhruv, Jeffrey A. Winkles, John Hicks, Jason T. Yustein, Lawrence A. Donehower, Sen Peng and Pulivarthi H. Rao and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and Journal of Virology.

In The Last Decade

Alison Roos

13 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alison Roos United States 10 207 121 87 81 67 16 360
Fangling Cheng China 9 153 0.7× 96 0.8× 68 0.8× 87 1.1× 43 0.6× 18 339
Zhennan Tao China 11 218 1.1× 119 1.0× 94 1.1× 87 1.1× 39 0.6× 21 381
Kathleen S. Ensbey Australia 12 251 1.2× 72 0.6× 138 1.6× 86 1.1× 35 0.5× 22 430
Shi-Yuan Cheng United States 9 306 1.5× 148 1.2× 95 1.1× 66 0.8× 32 0.5× 9 412
Raphaêl Lis United States 9 213 1.0× 168 1.4× 207 2.4× 101 1.2× 40 0.6× 10 448
Raffaella Albano Italy 6 158 0.8× 86 0.7× 130 1.5× 73 0.9× 64 1.0× 8 366
Valerio Ortenzi Italy 10 132 0.6× 85 0.7× 86 1.0× 127 1.6× 38 0.6× 25 340
Jennifer B. Edwards United States 8 284 1.4× 115 1.0× 84 1.0× 113 1.4× 48 0.7× 9 444
Maxim Sidorov United States 7 182 0.9× 72 0.6× 117 1.3× 68 0.8× 29 0.4× 9 328
K. Jin Kim United States 6 204 1.0× 59 0.5× 140 1.6× 46 0.6× 58 0.9× 7 375

Countries citing papers authored by Alison Roos

Since Specialization
Citations

This map shows the geographic impact of Alison Roos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Roos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Roos more than expected).

Fields of papers citing papers by Alison Roos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Roos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Roos. The network helps show where Alison Roos may publish in the future.

Co-authorship network of co-authors of Alison Roos

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Roos. A scholar is included among the top collaborators of Alison Roos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Roos. Alison Roos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Beniwal, Angad, Landon J. Inge, Alison Roos, et al.. (2024). EGFRvIII Confers Sensitivity to Saracatinib in a STAT5-Dependent Manner in Glioblastoma. International Journal of Molecular Sciences. 25(11). 6279–6279. 2 indexed citations
3.
Roos, Alison, et al.. (2024). The frequency of HLA-DQ7 in patients at risk of coeliac disease: A haplotype to be reckoned with for screening?. Human Immunology. 85(6). 111158–111158. 1 indexed citations
4.
5.
6.
Roos, Alison & Sara A. Byron. (2019). Genomics-Enabled Precision Medicine for Cancer. Cancer treatment and research. 178. 137–169. 6 indexed citations
7.
Roos, Alison, Harshil Dhruv, Sen Peng, et al.. (2018). EGFRvIII–Stat5 Signaling Enhances Glioblastoma Cell Migration and Survival. Molecular Cancer Research. 16(7). 1185–1195. 39 indexed citations
8.
Hersh, David S., Bryan Harder, Alison Roos, et al.. (2018). The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistance. Neuro-Oncology. 20(10). 1321–1330. 31 indexed citations
9.
Ding, Zonghui, Alison Roos, Jean Kloss, et al.. (2017). A Novel Signaling Complex between TROY and EGFR Mediates Glioblastoma Cell Invasion. Molecular Cancer Research. 16(2). 322–332. 12 indexed citations
10.
Roos, Alison, Zonghui Ding, Joseph C. Loftus, & Nhan L. Tran. (2017). Molecular and Microenvironmental Determinants of Glioma Stem-Like Cell Survival and Invasion. Frontiers in Oncology. 7. 120–120. 71 indexed citations
11.
Roos, Alison, Harshil Dhruv, Ian T. Mathews, et al.. (2017). Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells. Oncotarget. 8(7). 12234–12246. 36 indexed citations
12.
Ensign, Shannon P. Fortin, Alison Roos, Ian T. Mathews, et al.. (2016). SGEF Is Regulated via TWEAK/Fn14/NF-κB Signaling and Promotes Survival by Modulation of the DNA Repair Response to Temozolomide. Molecular Cancer Research. 14(3). 302–312. 14 indexed citations
13.
Roos, Alison, Shuying Zhao, Daniel G. Fuja, et al.. (2015). Loss of Runx2 sensitises osteosarcoma to chemotherapy-induced apoptosis. British Journal of Cancer. 113(9). 1289–1297. 24 indexed citations
14.
Zhao, Sibo, Lyazat Kurenbekova, Ying Gao, et al.. (2015). NKD2, a negative regulator of Wnt signaling, suppresses tumor growth and metastasis in osteosarcoma. Oncogene. 34(39). 5069–5079. 102 indexed citations
15.
Dhruv, Harshil, Alison Roos, Patrick Tomboc, et al.. (2015). Propentofylline inhibits glioblastoma cell invasion and survival by targeting the TROY signaling pathway. Journal of Neuro-Oncology. 126(3). 397–404. 9 indexed citations
16.
Robles, Maria Teresa Sáenz, et al.. (2013). Two Independent Regions of Simian Virus 40 T Antigen Increase CBP/p300 Levels, Alter Patterns of Cellular Histone Acetylation, and Immortalize Primary Cells. Journal of Virology. 87(24). 13499–13509. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fangling Cheng Breakdown of academic impact, for papers by Zhennan Tao Breakdown of academic impact, for papers by Kathleen S. Ensbey Breakdown of academic impact, for papers by Shi-Yuan Cheng Breakdown of academic impact, for papers by Raphaêl Lis Breakdown of academic impact, for papers by Raffaella Albano Breakdown of academic impact, for papers by Valerio Ortenzi Breakdown of academic impact, for papers by Jennifer B. Edwards Breakdown of academic impact, for papers by Maxim Sidorov Breakdown of academic impact, for papers by K. Jin Kim
Rankless by CCL
2026